Telminita-M 25 Tablet ER
Marketer
Ednita Healthcare
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Telminita-M 25 Tablet ER
Telminita-M 25 ER tablets manage hypertension, reducing the risk of stroke and heart attack. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking this medication with food daily, at the same time, as directed by your physician. Continued use is crucial, even without symptoms, as discontinuation can worsen hypertension. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, complement this treatment. Adhere strictly to your doctor's instructions. Potential side effects include headache, fatigue, dizziness, low blood pressure, elevated potassium, orthostatic hypotension (potentially causing fainting), shortness of breath, nausea, vomiting, abdominal pain, and weakness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from seated positions. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor about pre-existing liver or kidney conditions, pregnancy, breastfeeding, or other medications, particularly those for hypertension or heart issues, before commencing treatment.
Uses of Telminita-M 25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Telminita-M 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telminita-M 25 Tablet ER whole; avoid crushing, chewing, or breaking it. Administer this extended-release tablet with a meal.
Common Side effects of Telminita-M 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Telminita-M 25 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Telminita-M 25 Tablet ER with a meal.
How Telminita-M 25 Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Telminita-M 25 ER tablets, provide extended-release hypertension management.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Telminita-M 25 Tablet ER is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telminita-M 25mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Telminita-M 25mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Telminita-M 25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Telminita-M 25 mg tablets are considered safe for use in individuals with kidney impairment. No modification to the Telminita-M 25 mg extended-release tablet dosage is advised.
LiverCAUTION
Extended-release Telminita-M 25 mg tablets require careful administration for individuals with hepatic impairment. Dosage modification of Telminita-M 25 mg ER tablets might be necessary. Physician consultation is advised.
What if you forget to take Telminita-M 25 Tablet ER :
Should you forget to take a Telminita-M 25 Tablet ER, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telminita-M 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |
3,018 People bought this recently